Showing results (421-430 of 974) with videos related to

Sort By:
Pageof 98
Therapeutic Advances in Medical Oncology|November 25, 2024
Phase II trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors SWOG/NCI experience: invasive mucinous or non-mucinous lepidic adenocarcinoma of the lung (formerly bronchioloalveolar carcinoma)Young Kwang Chae, Megan Othus, Sandip Pravin Patel, et al.
Lung Cancer (Amsterdam, Netherlands)|November 19, 2019
Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancerDavid E Gerber, D Ross Camidge, Daniel Morgensztern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2024
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung CancerMitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 27, 2018
Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLCScott Gettinger, Matthew D Hellmann, Laura Q M Chow, et al.
Frontiers in Immunology|May 1, 2024
Highly variable timing renders immunotherapy efficacy and toxicity impractical biomarkers of one another in clinical practiceMitchell S von Itzstein, Yuqiu Yang, Yiqing Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung CancerScott Gettinger, Naiyer A Rizvi, Laura Q Chow, et al.
JCO Oncology Practice|May 10, 2021
Accessing Targeted Therapies: A Potential Roadblock to Implementing Precision Oncology?Mitchell S von Itzstein, Mary L Smith, Elda Railey, et al.
Journal for Immunotherapy of Cancer|June 15, 2021
Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitorsMurtaza Ahmed, Mitchell S von Itzstein, Thomas Sheffield, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Health Beliefs and Adherence to Lung Cancer Screening in a Diverse Safety-Net PopulationSheena Bhalla, Heidi A Hamann, Tanushree Prasad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Nivolumab in Combination With Platinum-Based Doublet Chemotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung CancerNaiyer A Rizvi, Matthew D Hellmann, Julie R Brahmer, et al.
Pageof 98